JUDITH YEGO: Open Payments
NPI 1760959431 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 35 payments from 11 companies in 2025. Trend: 2023 $185 · 2024 $821 · 2025 $747
Food & beverage: $732Education: $15
| Company | Payments | Amount |
|---|---|---|
| Recor Medical Inc | 5 | $173 |
| SCPHARMACEUTICALS INC. | 11 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Calliditas Therapeutics US Inc. | 2 | $47 |
| CorMedix Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| AKEBIA THERAPEUTICS INC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Paradise Ultrasound Renal Denervation System, FUROSCIX, TARPEYO, DEFENCATH, GATTEX, JARDIANCE, FARXIGA, Vafseo.
Industry payments across MI — which companies pay providers there.
